A detailed history of Crescent Grove Advisors, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Crescent Grove Advisors, LLC holds 7,719 shares of PFE stock, worth $199,381. This represents 0.02% of its overall portfolio holdings.

Number of Shares
7,719
Previous 8,860 12.88%
Holding current value
$199,381
Previous $247,000 9.72%
% of portfolio
0.02%
Previous 0.03%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$27.7 - $31.39 $31,605 - $35,815
-1,141 Reduced 12.88%
7,719 $223,000
Q2 2024

Jul 22, 2024

SELL
$25.26 - $29.6 $180,861 - $211,936
-7,160 Reduced 44.69%
8,860 $247,000
Q1 2024

Apr 29, 2024

SELL
$25.89 - $29.73 $4,686 - $5,381
-181 Reduced 1.12%
16,020 $444,000
Q4 2023

Jan 30, 2024

SELL
$26.13 - $33.94 $14,867 - $19,311
-569 Reduced 3.39%
16,201 $466,000
Q3 2023

Oct 25, 2023

SELL
$32.09 - $37.51 $24,163 - $28,245
-753 Reduced 4.3%
16,770 $556,000
Q2 2023

Jul 13, 2023

SELL
$36.12 - $41.79 $12,750 - $14,751
-353 Reduced 1.97%
17,523 $642,000
Q1 2023

May 03, 2023

BUY
$39.39 - $51.28 $3,702 - $4,820
94 Added 0.53%
17,876 $729,000
Q4 2022

Jan 12, 2023

SELL
$41.75 - $54.5 $39,036 - $50,957
-935 Reduced 5.0%
17,782 $0
Q3 2022

Nov 08, 2022

SELL
$43.76 - $53.42 $187,467 - $228,851
-4,284 Reduced 18.63%
18,717 $819,000
Q2 2022

Jul 20, 2022

SELL
$46.53 - $55.17 $68,026 - $80,658
-1,462 Reduced 5.98%
23,001 $1.21 Million
Q1 2022

May 04, 2022

BUY
$45.75 - $56.69 $516,151 - $639,576
11,282 Added 85.59%
24,463 $1.27 Million
Q4 2021

Jan 24, 2022

BUY
$41.32 - $61.25 $26,238 - $38,893
635 Added 5.06%
13,181 $778,000
Q3 2021

Oct 26, 2021

SELL
$39.25 - $50.42 $201,509 - $258,856
-5,134 Reduced 29.04%
12,546 $540,000
Q2 2021

Jul 26, 2021

SELL
$35.91 - $40.68 $22,443 - $25,425
-625 Reduced 3.41%
17,680 $692,000
Q1 2021

May 07, 2021

BUY
$33.49 - $37.77 $80,242 - $90,496
2,396 Added 15.06%
18,305 $663,000
Q4 2020

Feb 01, 2021

BUY
$33.47 - $42.56 $6,660 - $8,469
199 Added 1.27%
15,909 $586,000
Q3 2020

Nov 06, 2020

SELL
$31.75 - $37.25 $28,892 - $33,897
-910 Reduced 5.48%
15,710 $577,000
Q2 2020

Aug 03, 2020

SELL
$30.12 - $36.54 $23,614 - $28,647
-784 Reduced 4.5%
16,620 $543,000
Q1 2020

Apr 27, 2020

BUY
$27.03 - $38.62 $20,704 - $29,582
766 Added 4.6%
17,404 $568,000
Q4 2019

Feb 03, 2020

BUY
$32.92 - $37.36 $98 - $112
3 Added 0.02%
16,638 $652,000
Q3 2019

Oct 31, 2019

SELL
$32.49 - $42.13 $108,094 - $140,166
-3,327 Reduced 16.67%
16,635 $598,000
Q2 2019

Aug 06, 2019

SELL
$36.98 - $41.52 $20,117 - $22,586
-544 Reduced 2.65%
19,962 $865,000
Q1 2019

May 13, 2019

SELL
$37.5 - $41.2 $55,875 - $61,388
-1,490 Reduced 6.77%
20,506 $871,000
Q4 2018

Jan 29, 2019

BUY
$38.47 - $43.86 $8,809 - $10,043
229 Added 1.05%
21,996 $960,000
Q3 2018

Nov 05, 2018

BUY
$34.47 - $41.81 $68 - $83
2 Added 0.01%
21,767 $959,000
Q2 2018

Jul 16, 2018

SELL
$32.98 - $35.16 $147,981 - $157,762
-4,487 Reduced 17.09%
21,765 $790,000
Q1 2018

May 03, 2018

SELL
$31.91 - $37.02 $113,950 - $132,198
-3,571 Reduced 11.97%
26,252 $932,000
Q4 2017

Feb 06, 2018

SELL
$33.26 - $35.29 $56,242 - $59,675
-1,691 Reduced 5.37%
29,823 $1.08 Million
Q3 2017

Nov 06, 2017

BUY
$31.0 - $34.15 $976,934 - $1.08 Million
31,514
31,514 $1.13 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $145B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Crescent Grove Advisors, LLC Portfolio

Follow Crescent Grove Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crescent Grove Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crescent Grove Advisors, LLC with notifications on news.